To include your compound in the COVID-19 Resource Center, submit it here.

SB1518: Phase II started

S*Bio began an open-label, U.S. and Canadian Phase II trial in up

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE